Table 1 Characteristics of the study participants.
Characteristics | Q1 | Q2 | Q3 | Q4 | P-value |
---|---|---|---|---|---|
N | 85 | 85 | 88 | 87 | Â |
Primary outcome | |||||
 Length of hospitalization, days | 6.4 ± 4.2 | 5.4 ± 2.0 | 4.8 ± 1.8 | 5.1 ± 1.9 | 0.013 |
Demographics | |||||
 Age, years | 62.2 ± 12.3 | 60.9 ± 10.9 | 55.1 ± 11.4 | 53.9 ± 11.9 | < 0.001 |
 Female, n (%) | 16 (18.8%) | 16 (19.0%) | 12 (13.6%) | 12 (13.8%) | 0.632 |
 Cardiovascular risk factors |  |  |  |  |  |
 Hypertension, n (%) | 42 (53.2%) | 47 (56.0%) | 47 (56.0%) | 42 (50.0%) | 0.846 |
 Diabetes mellitus, n (%) | 19 (24.1%) | 25 (29.8%) | 25 (29.8%) | 22 (26.2%) | 0.807 |
 Hypertriglyceridemia, n (%) | 16 (20.3%) | 23 (27.4%) | 26 (31.0%) | 26 (31.0%) | 0.379 |
 Smoking, n (%) | 47 (59.5%) | 53 (63.1%) | 60 (71.4%) | 60 (71.4%) | 0.261 |
Other past disorders | |||||
 OMI, n (%) | 1 (1.3%) | 2 (2.4%) | 1 (1.2%) | 5 (6.0%) | 0.193 |
 CRF, n (%) | 1 (1.3%) | 3 (3.6%) | 1 (1.2%) | 2 (2.4%) | 0.680 |
 Stroke, n (%) | 3 (3.8%) | 7 (8.3%) | 4 (4.8%) | 8 (9.5%) | 0.389 |
 CHF, n (%) | 1 (1.3%) | 1 (1.2%) | 0 (0.0%) | 2 (2.4%) | 0.573 |
 History of PCI, n (%) | 0 (0.0%) | 3 (3.6%) | 3 (3.6%) | 6 (7.1%) | 0.114 |
Laboratory tests | |||||
 WBC,109/L | 9.9 ± 3.4 | 9.7 ± 3.0 | 9.8 ± 3.8 | 10.0 ± 3.5 | 0.958 |
 PLT,109/L | 211.4 ± 70.4 | 226.3 ± 60.4 | 245.7 ± 67.3 | 252.4 ± 58.6 | < 0.001 |
 HGB, g/L | 139.5 ± 18.6 | 144.3 ± 18.9 | 145.6 ± 17.9 | 152.0 ± 15.8 | < 0.001 |
 Hs-CRP, mg/L | 17.5 ± 50.9 | 11.8 ± 39.9 | 9.1 ± 25.6 | 4.9 ± 13.0 | 0.135 |
 K+, mmol/L | 4.0 ± 0.4 | 4.0 ± 0.3 | 4.0 ± 0.3 | 4.0 ± 0.4 | 0.929 |
 BG, mmol/L | 9.5 ± 5.1 | 8.9 ± 4.0 | 8.1 ± 3.6 | 8.3 ± 4.6 | 0.156 |
 CTnI, ng/mL | 2.6 ± 5.9 | 1.8 ± 4.7 | 1.3 ± 3.0 | 1.9 ± 5.3 | 0.313 |
 ALB, g/L | 34.5 ± 2.1 | 38.6 ± 0.8 | 41.1 ± 0.7 | 44.9 ± 2.1 | < 0.001 |
 LDL-C, mmol/L | 3.0 ± 1.1 | 2.9 ± 0.9 | 3.8 ± 5.2 | 3.2 ± 1.2 | 0.093 |
 HDL-C, mmol/L | 1.0 ± 0.2 | 1.2 ± 1.2 | 1.0 ± 0.3 | 1.1 ± 0.2 | 0.305 |
 LVEF, % | 57.4 ± 7.0 | 57.8 ± 9.7 | 58.9 ± 8.9 | 56.7 ± 10.3 | 0.302 |
Criminal Vessels | Â | Â | Â | Â | 0.044 |
 LM, n (%) | 2 (2.4%) | 2 (2.4%) | 1 (1.1%) | 1 (1.1%) |  |
 LAD, n (%) | 37 (43.5%) | 40 (47.1%) | 56 (63.6%) | 56 (64.4%) |  |
 LCX, n (%) | 8 (9.4%) | 13 (15.3%) | 12 (13.6%) | 9 (10.3%) |  |
 RCA, n (%) | 38 (44.7%) | 30 (35.3%) | 19 (21.6%) | 21 (24.1%) |  |
 IVUS, n (%) | 61 (71.8%) | 50 (58.8%) | 55 (62.5%) | 54 (62.8%) | 0.341 |
 IABP, n (%) | 11 (12.9%) | 5 (5.9%) | 1 (1.1%) | 1 (1.1%) | 0.001 |